Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Erbez Georgia Create: Alert

All | News | Filings
Date FiledTypeDescription
02/04/2020 4 Erbez Georgia (CFO) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 52,160 options to buy @ $13.29, valued at $693.2k
01/23/2020 4 Erbez Georgia (CFO) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Bought 6,700 shares @ $14.0922, valued at $94.4k
12/06/2019 4 Erbez Georgia (CFO) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Exercised 47,292 options to buy @ $2.12, valued at $100.3k
08/30/2019 4 Erbez Georgia (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns: Granted 22,250 options to buy @ $1.99, valued at $44.3k
06/21/2019 3 Erbez Georgia (Director) has filed a Form 3 on ARTELO BIOSCIENCES, INC.
02/07/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
05/25/2017 4 Erbez Georgia (CFO and Chief Business Officer) has filed a Form 4 on Zosano Pharma Corp
Txns: Bought 68,000 shares @ $1.32, valued at $89.8k
09/09/2016 4 Erbez Georgia (CBO and Interim CFO) has filed a Form 4 on Zosano Pharma Corp
08/22/2016 4 Erbez Georgia (Interim CFO) has filed a Form 4 on Zosano Pharma Corp
06/24/2016 3 Erbez Georgia (Interim CFO) has filed a Form 3 on Zosano Pharma Corp
11/12/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
05/15/2014 4 Erbez Georgia (CFO) has filed a Form 4 on Raptor Pharmaceutical Corp
Txns: Bought 16,100 shares @ $7.9, valued at $127.2k
02/11/2014 4 Erbez Georgia (CFO) has filed a Form 4 on Raptor Pharmaceutical Corp
Txns: Granted 83,800 options to buy @ $14.74, valued at $1.2M
09/03/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
09/12/2012 4 Erbez Georgia (CFO) has filed a Form 4 on Raptor Pharmaceutical Corp
Txns: Granted 190,000 options to buy @ $5.27, valued at $1M
09/12/2012 3 Erbez Georgia (CFO) has filed a Form 3 on Raptor Pharmaceutical Corp

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy